HomeCSTL • NASDAQ
add
Castle Biosciences Inc
Previous close
$24.22
Day range
$24.18 - $24.94
Year range
$9.26 - $26.70
Market cap
669.20M USD
Avg Volume
223.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 72.97M | 73.59% |
Operating expense | 64.55M | 1.85% |
Net income | -2.53M | 91.32% |
Net profit margin | -3.47 | 95.01% |
Earnings per share | -0.09 | 91.82% |
EBITDA | -2.13M | 92.56% |
Effective tax rate | -1.81% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 239.21M | 3.08% |
Total assets | 458.51M | 7.41% |
Total liabilities | 56.04M | 34.27% |
Total equity | 402.46M | — |
Shares outstanding | 27.61M | — |
Price to book | 1.66 | — |
Return on assets | -3.00% | — |
Return on capital | -3.28% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.53M | 91.32% |
Cash from operations | -6.84M | 73.13% |
Cash from investing | -19.70M | -218.80% |
Cash from financing | 10.64M | 1,362.09% |
Net change in cash | -15.89M | -95.55% |
Free cash flow | -16.28M | 8.76% |
About
Founded
2007
Headquarters
Website
Employees
638